Physician profile
Thomas Robert Nettleton
NPI 1497108435
$10,089.15
in general payments reported to CMS, 2019-2025
29 companies · $917 in 2025
The $917 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $351 · 2021: $2,480 · 2022: $3,954 · 2023: $992 · 2024: $890 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,739 · Entertainment: $42.25 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,739.27 |
| Entertainment | $42.25 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $5,797.86 | 2021-2025 | Photrexa Viscous and Photrexa, Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Biotissue Holdings INC. | $827.86 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $527.51 | 2021-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $427.33 | 2019-2025 | Tecnis Iol, Veritas Vision System, One Series Ultra |
| Amgen INC. | $319.02 | 2024-2025 | Tepezza |
| Abbvie INC. | $272.93 | 2023-2025 | |
| Rxsight INC | $199.00 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $163.21 | 2019-2023 | |
| Quidel Corporation | $160.67 | 2019 | |
| Harrow Eye, LLC | $159.21 | 2024-2025 | Vevye, Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.12 | 2019-2021 | |
| Horizon Therapeutics Plc | $139.93 | 2022-2023 | Tepezza |
| Lkc Technologies, INC. | $132.24 | 2025 | |
| Oyster Point Pharma, INC. | $108.92 | 2022-2024 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $107.58 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $86.23 | 2021-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $81.93 | 2023-2024 | Miebo, Xiidra, Alrex |
| Sight Sciences, INC. | $65.66 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $60.40 | 2025 | Xdemvy |
| Shire North American Group INC | $56.44 | 2019 | |
| Alcon Vision LLC | $49.85 | 2022 | |
| Thea Pharma INC. | $47.91 | 2023-2024 | |
| Optos, INC. | $42.25 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Ani Pharmaceuticals, INC. | $33.90 | 2024 | Purified Cortrophin Gel |
| Ocular Therapeutix, INC. | $20.98 | 2024 | Dextenza |
| Rayner Intraocular Lenses Limited | $16.61 | 2025 | Rayone Emv, Rayone Aspheric, Rayner Cataract Set 1 |
| Oasis Medical, INC. | $15.96 | 2022 | |
| Tearlab Corp | $14.17 | 2023 | Tearlab Osmolarity System |
| Staar Surgical Company | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nettleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.